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BBrain tumors are typically composed of morpho-
ogically diverse cells that express a variety of neural
ineage markers. Study of brain tumors by traditional
istopathology has yielded only a limited amount of
nowledge of the clinical behavior of the tumor. It is
ecognized that tumors with vastly different histology
ave a different prognosis, but often brain tumors that
hare similar morphology and phenotype can have a
ery different prognosis and response to treatment.
lthough major advances have been made in the un-
erstanding of the molecular genetic alterations of
ome types of brain tumors [1,2], particularly medul-
oblastomas and malignant gliomas, and although
ome of these identiﬁed alterations are now beginning
o guide treatment, it is not clear whether all tumor
ells are equivalent in their ability to maintain the
rowth of the tumor. Until recently, we lacked a
unctional assay of the brain tumor cells that could
etermine which of the morphologically diverse tu-
or cells are capable of maintaining the growth of the
umor.
The cancer stem cell hypothesis suggests that not
ll cells in the tumor have the same ability to prolif-
rate and maintain the growth of the tumor. Only a
elatively small fraction of cells in the tumor, termed
ancer stem cells, possess the ability to extensively pro-
iferate and self-renew. Most of the tumor cells lose
he ability to proliferate and self-renew, and they dif-
erentiate into tumor cells that become the phenotypic
ignature of the tumor. Finding the key cells in the
rain tumor population that are able to maintain the
umor will give insight into the mechanism of brain
umorigenesis and will allow us to trace back to the
ell of origin. A normal neural stem cell could be the
ell of origin for a brain tumor, but this idea remains
argely speculative, and there are data that suggest r
2oth neural progenitors and neural stem cells are
ossible cells of origin [1,2].
Recent evidence, however, suggests that brain tu-
ors contain small numbers of cells with neural stem
ell properties [3-7]. These cells have the ability to
elf-renew, proliferate, and differentiate in vitro. Most
f these studies made a stem cell connection on the
asis of the ability of the brain tumor cells to form
lonogenically derived colonies of cells in the culture,
nalogous to normal neurospheres [8], that derive
rom neural stem cells in deﬁned culture conditions
no cell adhesion, serum free, in epidermal growth
actor and ﬁbroblast growth factor). The stem cell
ature of tumors is deﬁned retrospectively by their
bility to form these “neurospheres” and by their
elf-renewal and multilineage differentiation ability in
ulture.
The ﬁrst prospective in vitro identiﬁcation and
haracterization of a cancer stem cells from human
rain tumors of different phenotypes was reported on
he basis of cell sorting for CD133 on acutely disso-
iated brain tumor cell populations [5]. CD133 had
een previously used to identify normal human neural
tem cells [9]. The brain tumor stem cell (BTSC)
epresented a fraction of the total cells comprising the
umor and was isolated from low-grade and high-
rade tumors from both children and adults. The
TSC was exclusively isolated with the cell fraction
xpressing the neural stem cell surface marker CD133.
hree pieces of evidence suggested that these cells
ere BTSCs: (1) they generated clusters of clonally
erived cells resembling neurospheres, (2) they under-
ent self-renewal and proliferation, and (3) they dif-
erentiated to recapitulate the phenotype of the tumor
rom which they were derived. In deﬁning a class of
TSCs that can be prospectively isolated from a wide
ange of brain tumors, these data supported the appli-
c
n
s
t
W
p
p
t
a
t
t
g
t
I
s
g
m
a
i
B
c
n
m
g
w
r
g
r
a
i
t
g
c
o
C
c
n
d
i
t
i
c
o
f
i
m
1
t
o
p
i
p
p
s
m
f
R
1
Brain Tumor Stem Cells
Bation of principles of leukemogenesis to solid tumors:
amely, the principle that only a small subset of cancer
tem cells is enriched for clonogenic capacity and that
hese cells alone are capable of tumor propagation.
e believe that further research is required to further
urify the BTSCs, because we hypothesize that a more
otent BTSC will be found in a CD133 subpopula-
ion.
Another report, by Hemmati et al. [4], substanti-
ted this ﬁnding of cancer stem cells in pediatric brain
umors. They found that pediatric brain tumors con-
ained neural stemlike cells, termed tumor-derived pro-
enitors, that showed the capacity for sphere forma-
ion, self-renewal, and multipotential differentiation.
n addition, these cells were shown by reverse tran-
criptase-polymerase chain reaction to express many
enes characteristic of neural stem cells, including
usashi-1, Sox2, bmi-1, and CD133. Further reports
re emerging that document the presence of BTSCs
n human adult brain tumors [6,7]. The description of
TSCs from a number of groups describes a class of
ells that may drive tumorigenesis in an increasing
umber of brain tumors.
Despite the intriguing in vitro data, the only true
easures of cancer stem cells are their capacity to
enerate an exact copy of the tumor from which they
ere derived and to self-renew, and these measures
equire in vivo data. Galli et al. [7] demonstrated that
lioblastoma cell lines, established by culture in neu-
osphere (neural stem cell) conditions, could prolifer-
te, self-renew, and differentiate into multiple lineages
n vitro. Further cerebral injection of 200 000 of these
umor sphere cells into mice intracranially could also
enerate tumors in vivo and, after repeat culture,
ould initiate phenotypically similar tumors in a sec-
nd mouse.
Our own further work now also suggests that
D133 can purify a subpopulation of brain tumor
ells that are capable of tumor initiation and mainte-
ance in in vivo models. We recently reported the
evelopment of a xenograft assay that we used to
dentify human brain tumor–initiating cells that had
he capacity to initiate tumors in vivo [10]. CD133
solation and in vivo engraftment were performed on
B&MTells that had only an extremely brief time in culture
r no culture at all. Only the CD133 brain tumor
raction contained cells that were capable of tumor
nitiation in nonobese diabetic/severe combined im-
unodeﬁciency mouse brains. Injection of as few as
00 CD133 cells produced a tumor that was serially
ransplantable and was a phenocopy of the patient’s
riginal tumor, whereas injection of 105 CD133 cells
roduced engraftment but did not cause a tumor. The
dentiﬁcation of a brain tumor–initiating cell in vivo
rovides further insights into human brain tumor
athogenesis and gives strong support for the cancer
tem cell hypothesis as the basis for many solid tu-
ors, thus further establishing a novel cellular target
or more effective cancer therapies.
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